HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Clerico Selected Research

Glatiramer Acetate (Copaxone)

4/2008Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Clerico Research Topics

Disease

6Multiple Sclerosis
11/2009 - 02/2006
2Relapsing-Remitting Multiple Sclerosis
04/2008 - 04/2001
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2000
1Lung Neoplasms (Lung Cancer)
10/2000
1Brain Neoplasms (Brain Tumor)
10/2000
1Neoplasms (Cancer)
10/2000

Drug/Important Bio-Agent (IBA)

5Interferon-betaIBA
11/2009 - 04/2001
1Neutralizing AntibodiesIBA
04/2009
1InterferonsIBA
06/2008
1Immunomodulating AgentsIBA
04/2008
1Glatiramer Acetate (Copaxone)FDA Link
04/2008
1Interferon beta-1b (Betaseron)FDA Link
02/2006
1Interferon beta-1aFDA Link
02/2006
1Teniposide (VM 26)FDA Link
10/2000

Therapy/Procedure

2Therapeutics
10/2009 - 10/2000
1Drug Therapy (Chemotherapy)
10/2000
1Radiotherapy
10/2000